BSP Pharmaceuticals S.p.A. is glad to announce its participation into the 58th AFI Symposium. This year the Symposium topic will be the transformations of the pharmaceutical industry in the digital era.
Thanks to innovations and new technologies, big improvements are taking place in the drugs development field and in the patients care area: some aspects of the drugs development process are now digitalized as the business model definition in the choice of treatments.
In the digital era, pharmaceutical companies are now aware that they should not focus only on the actual production of drugs, but they should also work on the development of digital apps, medical devices and services.
This new strategy is called 'beyond-the-pill'.
The scientific part of the symposium is going to be divided into 13 Sessions, where different themes will be addressed, in order to allow participants to follow only the topics they are interested to.
On the 7th of June at 11.35 AM, during Session IV, 'Industry 4.0 and Innovation - The pharmaceutical production', Maria Elena Guadagno, BSP Business Director, and Filippo Trionfera, BSP Q.P. & Quality Assurance Manager, will make a presentation on 'Innovative productions - ADC production (Antibody Drug Conjugates) as API and Final Product: from the origin to the production'.
